China Drugs for Osteoarthritis Pain Market Research Report 2017

January 2017 | 117 pages | ID: C5A26F33365EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Drugs for Osteoarthritis Pain

Revenue, means the sales value of Drugs for Osteoarthritis Pain

This report studies Drugs for Osteoarthritis Pain in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Abbott Laboratories
• Johnson & Johnson
• Novartis International
• Pfizer
• AbbVie
• Abiogen Pharma
• Afferent Pharmaceuticals
• Astellas Pharma
• BioDelivery Sciences International
• CrystalGenomics
• Cytori Therapeutics
• Daiichi Sankyo
• Eli Lilly
• Endo Pharmaceuticals Holdings
• Horizon Pharma
• ICeutica
• Iroko Pharmaceuticals
• Merck
• Nuvo Research
• Regeneron Pharmaceuticals
• Sanofi
• SantoSolve
• Techfields Pharma
• Winston Pharmaceuticals
• Yooyoung Pharmaceutical
• Zynerba Pharmaceuticals

Market Segment by Regions (provinces), covering

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• OTC
• Prescription

Split by Application, this report focuses on consumption, market share and growth rate of Drugs for Osteoarthritis Pain in each application, can be divided into

• Hospital
• Clinics
• Household

Contents

China Drugs for Osteoarthritis Pain Market Research Report 2017

1 DRUGS FOR OSTEOARTHRITIS PAIN MARKET OVERVIEW

1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Drugs for Osteoarthritis Pain Segment by Type
  1.2.1 China Production Market Share of Drugs for Osteoarthritis Pain Type in 2015
  1.2.2 OTC
  1.2.3 Prescription
1.3 Applications of Drugs for Osteoarthritis Pain
  1.3.1 Drugs for Osteoarthritis Pain Consumption Market Share by Application in 2015
  1.3.2 Hospital
  1.3.3 Clinics
  1.3.4 Household
1.4 China Market Size (Value) of Drugs for Osteoarthritis Pain (2011-2021)
1.5 China Drugs for Osteoarthritis Pain Status and Outlook
1.6 Government Policies

2 CHINA DRUGS FOR OSTEOARTHRITIS PAIN MARKET COMPETITION BY MANUFACTURERS

2.1 China Drugs for Osteoarthritis Pain Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Drugs for Osteoarthritis Pain Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Drugs for Osteoarthritis Pain Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Drugs for Osteoarthritis Pain Manufacturing Base Distribution, Sales Area, Product Type
2.5 Drugs for Osteoarthritis Pain Market Competitive Situation and Trends
  2.5.1 Drugs for Osteoarthritis Pain Market Concentration Rate
  2.5.2 Drugs for Osteoarthritis Pain Market Share of Top 3 and Top 5 Manufacturers

3 CHINA DRUGS FOR OSTEOARTHRITIS PAIN MANUFACTURERS PROFILES/ANALYSIS

3.1 Abbott Laboratories
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    3.1.2.1 OTC
    3.1.2.2 Prescription
  3.1.3 Abbott Laboratories Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Johnson & Johnson
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    3.2.2.1 OTC
    3.2.2.2 Prescription
  3.2.3 Johnson & Johnson 117 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Novartis International
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    3.3.2.1 OTC
    3.3.2.2 Prescription
  3.3.3 Novartis International 128 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Pfizer
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    3.4.2.1 OTC
    3.4.2.2 Prescription
  3.4.3 Pfizer Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 AbbVie
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    3.5.2.1 OTC
    3.5.2.2 Prescription
  3.5.3 AbbVie Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Abiogen Pharma
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    3.6.2.1 OTC
    3.6.2.2 Prescription
  3.6.3 Abiogen Pharma Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Afferent Pharmaceuticals
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    3.7.2.1 OTC
    3.7.2.2 Prescription
  3.7.3 Afferent Pharmaceuticals Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 Astellas Pharma
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    3.8.2.1 OTC
    3.8.2.2 Prescription
  3.8.3 Astellas Pharma Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 BioDelivery Sciences International
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    3.9.2.1 OTC
    3.9.2.2 Prescription
  3.9.3 BioDelivery Sciences International Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview
3.10 CrystalGenomics
  3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.10.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    3.10.2.1 OTC
    3.10.2.2 Prescription
  3.10.3 CrystalGenomics Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.10.4 Main Business/Business Overview
3.11 Cytori Therapeutics
3.12 Daiichi Sankyo
3.13 Eli Lilly
3.14 Endo Pharmaceuticals Holdings
3.15 Horizon Pharma
3.16 ICeutica
3.17 Iroko Pharmaceuticals
3.18 Merck
3.19 Nuvo Research
3.20 Regeneron Pharmaceuticals
3.21 Sanofi
3.22 SantoSolve
3.23 Techfields Pharma
3.24 Winston Pharmaceuticals
3.25 Yooyoung Pharmaceutical
3.26 Zynerba Pharmaceuticals

4 CHINA DRUGS FOR OSTEOARTHRITIS PAIN CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Drugs for Osteoarthritis Pain Capacity, Production and Growth (2011-2016)
4.2 China Drugs for Osteoarthritis Pain Revenue and Growth (2011-2016)
4.3 China Drugs for Osteoarthritis Pain Production, Consumption, Export and Import (2011-2016)

5 CHINA DRUGS FOR OSTEOARTHRITIS PAIN PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Drugs for Osteoarthritis Pain Production and Market Share by Type (2011-2016)
5.2 China Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2011-2016)
5.3 China Drugs for Osteoarthritis Pain Price by Type (2011-2016)
5.4 China Drugs for Osteoarthritis Pain Production Growth by Type (2011-2016)

6 CHINA DRUGS FOR OSTEOARTHRITIS PAIN MARKET ANALYSIS BY APPLICATION

6.1 China Drugs for Osteoarthritis Pain Consumption and Market Share by Application (2011-2016)
6.2 China Drugs for Osteoarthritis Pain Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CHINADRUGS FOR OSTEOARTHRITIS PAIN MARKET ANALYSIS BY REGIONS (PROVINCES)

7.1 China Drugs for Osteoarthritis Pain Production, Production Value and Price by Regions (Provinces)(2011-2016)
  7.1.1 China Drugs for Osteoarthritis Pain Production and Market Share by Regions (Provinces)(2011-2016)
  7.1.2 China Drugs for Osteoarthritis Pain Production Value and Market Share by Regions (Provinces)(2011-2016)
  7.1.3 China Drugs for Osteoarthritis Pain Sales Price by Regions (Provinces)(2011-2016)
7.2 China Drugs for Osteoarthritis Pain Consumption by Regions (Provinces)(2011-2016)
7.3 China Drugs for Osteoarthritis Pain Production, Consumption, Export and Import (2011-2016)

8 DRUGS FOR OSTEOARTHRITIS PAIN MANUFACTURING COST ANALYSIS

8.1 Drugs for Osteoarthritis Pain Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Drugs for Osteoarthritis Pain Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 CHINA DRUGS FOR OSTEOARTHRITIS PAIN MARKET FORECAST (2016-2021)

12.1 China Drugs for Osteoarthritis Pain Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Drugs for Osteoarthritis Pain Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Drugs for Osteoarthritis Pain Production Forecast by Type (2016-2021)
12.4 China Drugs for Osteoarthritis Pain Consumption Forecast by Application (2016-2021)
12.5 China Drugs for Osteoarthritis Pain Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  12.5.1 China Drugs for Osteoarthritis Pain Production Forecast by Regions (Provinces)(2016-2021)
  12.5.2 China Drugs for Osteoarthritis Pain Consumption Forecast by Regions (Provinces)(2016-2021)
  12.5.3 China Drugs for Osteoarthritis Pain Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Drugs for Osteoarthritis Pain Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Osteoarthritis Pain
Figure China Production Market Share of Drugs for Osteoarthritis Pain by Type in 2015
Figure Product Picture of OTC
Table Major Manufacturers of OTC
Figure Product Picture of Prescription
Table Major Manufacturers of Prescription
Table Drugs for Osteoarthritis Pain Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Clinics Examples
Figure Household Examples
Figure China Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2011-2021)
Table China Drugs for Osteoarthritis Pain Capacity of Key Manufacturers (2015 and 2016)
Table China Drugs for Osteoarthritis Pain Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Drugs for Osteoarthritis Pain Capacity of Key Manufacturers in 2015
Figure China Drugs for Osteoarthritis Pain Capacity of Key Manufacturers in 2016
Table China Drugs for Osteoarthritis Pain Production of Key Manufacturers (2015 and 2016)
Table China Drugs for Osteoarthritis Pain Production Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Osteoarthritis Pain Production Share by Manufacturers
Figure 2016 Drugs for Osteoarthritis Pain Production Share by Manufacturers
Table China Drugs for Osteoarthritis Pain Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Drugs for Osteoarthritis Pain Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Drugs for Osteoarthritis Pain Revenue Share by Manufacturers
Table 2016 China Drugs for Osteoarthritis Pain Revenue Share by Manufacturers
Table China Market Drugs for Osteoarthritis Pain Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Drugs for Osteoarthritis Pain Average Price of Key Manufacturers in 2015
Table Manufacturers Drugs for Osteoarthritis Pain Manufacturing Base Distribution and Sales Area
Table Manufacturers Drugs for Osteoarthritis Pain Product Type
Figure Drugs for Osteoarthritis Pain Market Share of Top 3 Manufacturers
Figure Drugs for Osteoarthritis Pain Market Share of Top 5 Manufacturers
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Drugs for Osteoarthritis Pain Market Share (2011-2016)
Table Novartis International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis International Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis International Drugs for Osteoarthritis Pain Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Drugs for Osteoarthritis Pain Market Share (2011-2016)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure AbbVie Drugs for Osteoarthritis Pain Market Share (2011-2016)
Table Abiogen Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abiogen Pharma Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abiogen Pharma Drugs for Osteoarthritis Pain Market Share (2011-2016)
Table Afferent Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Market Share (2011-2016)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Pharma Drugs for Osteoarthritis Pain Market Share (2011-2016)
Table BioDelivery Sciences International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Market Share (2011-2016)
Table CrystalGenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CrystalGenomics Drugs for Osteoarthritis Pain Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure CrystalGenomics Drugs for Osteoarthritis Pain Market Share (2011-2016)
Table Cytori Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Endo Pharmaceuticals Holdings Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Horizon Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ICeutica Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Iroko Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nuvo Research Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SantoSolve Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Techfields Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Winston Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Yooyoung Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zynerba Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Drugs for Osteoarthritis Pain Capacity, Production and Growth (2011-2016)
Figure China Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth (2011-2016)
Table China Drugs for Osteoarthritis Pain Production, Consumption, Export and Import (2011-2016)
Table China Drugs for Osteoarthritis Pain Production by Type (2011-2016)
Table China Drugs for Osteoarthritis Pain Production Share by Type (2011-2016)
Figure Production Market Share of Drugs for Osteoarthritis Pain by Type (2011-2016)
Figure 2015 Production Market Share of Drugs for Osteoarthritis Pain by Type
Table China Drugs for Osteoarthritis Pain Revenue by Type (2011-2016)
Table China Drugs for Osteoarthritis Pain Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Drugs for Osteoarthritis Pain by Type (2011-2016)
Figure 2015 Revenue Market Share of Drugs for Osteoarthritis Pain by Type
Table China Drugs for Osteoarthritis Pain Price by Type (2011-2016)
Figure China Drugs for Osteoarthritis Pain Production Growth by Type (2011-2016)
Table China Drugs for Osteoarthritis Pain Consumption by Application (2011-2016)
Table China Drugs for Osteoarthritis Pain Consumption Market Share by Application (2011-2016)
Figure China Drugs for Osteoarthritis Pain Consumption Market Share by Application in 2015
Table China Drugs for Osteoarthritis Pain Consumption Growth Rate by Application (2011-2016)
Figure China Drugs for Osteoarthritis Pain Consumption Growth Rate by Application (2011-2016)
Table China Drugs for Osteoarthritis Pain Production by Regions (Provinces)(2011-2016)
Table China Drugs for Osteoarthritis Pain Production Market Share by Regions (Provinces)(2011-2016)
Table China Drugs for Osteoarthritis Pain Production Value by Regions (Provinces)(2011-2016)
Table China Drugs for Osteoarthritis Pain Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Drugs for Osteoarthritis Pain Sales Price by Regions (Provinces)(2011-2016)
Table China Drugs for Osteoarthritis Pain Consumption by Regions (Provinces)(2011-2016)
Table China Drugs for Osteoarthritis Pain Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Drugs for Osteoarthritis Pain Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Osteoarthritis Pain
Figure Manufacturing Process Analysis of Drugs for Osteoarthritis Pain
Figure Drugs for Osteoarthritis Pain Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015
Table Major Buyers of Drugs for Osteoarthritis Pain
Table Distributors/Traders List
Figure China Drugs for Osteoarthritis Pain Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)
Table China Drugs for Osteoarthritis Pain Production, Import, Export and Consumption Forecast (2016-2021)
Table China Drugs for Osteoarthritis Pain Production Forecast by Type (2016-2021)
Table China Drugs for Osteoarthritis Pain Consumption Forecast by Application (2016-2021)
Table China Drugs for Osteoarthritis Pain Production Forecast by Regions (Provinces)(2016-2021)
Table China Drugs for Osteoarthritis Pain Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Drugs for Osteoarthritis Pain Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)